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Abstract
While performing molecular conﬁrmation of phenotypically identiﬁed Candida tropicalis isolates, we re-identiﬁed a few isolates as Kodamaea
ohmeri. This led us to the present epidemiological investigation of K. ohmeri fungaemia cases. All phenotypically identiﬁed C. tropicalis blood
isolates during October 2008 through to December 2009 at our advanced paediatric centre were included for molecular identiﬁcation by
sequencing of the internal transcribed spacer and D1/D2 regions of rDNA. After identifying a large cluster K. ohmeri fungaemia cases, a
case–control study was carried out retrospectively to analyse potential risk factors for K. ohmeri fungaemia. Molecular typing of the isolates
was performed using a ﬂuorescent ampliﬁed fragment length polymorphism (FAFLP) technique. The antifungal susceptibility testing was
performed as per the M27-A3 protocol of CLSI. Thirty-eight (25.7%) of 148 phenotypically identiﬁed C. tropicalis isolates were conﬁrmed as
K. ohmeri by sequencing and FAFLP. By case–control analysis, piperacillin-tazobactam was signiﬁcantly associated with the K. ohmeri
fungaemia. The FAFLP analysis showed that all K. ohmeri isolates had >92% similarity. The azoles and echinocandins had good in vitro activity
against K. ohmeri, though 86.8% of the isolates had MIC of 1 mg/L for amphotericin B. The response to antifungal therapy could be evaluated
in 27 patients and 70.4% of patients recovered after antifungal therapy. The present study reports the largest cluster of K. ohmeri fungaemia
from a single centre. The study also stresses the need for accurate identiﬁcation of clinical yeast isolates.
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